Alerts will be sent to your verified email
Verify Email
RPGLIFE
|
RPG Life Sciences
|
Orchid Pharma
|
Advanced Enzyme
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
-11.18 % | n/a | n/a |
|
R&D as a % of Total Sales
|
1.11 % | n/a | 10.41 % |
|
Financials
|
|||
|
5 yr Average ROE
|
23.71 % | 0.86 % | 10.77 % |
|
5yr average Equity Multiplier
|
1.34 | 1.61 | 1.15 |
|
5yr Average Asset Turnover Ratio
|
1.18 | 0.5 | 0.41 |
|
5yr Avg Net Profit Margin
|
15.65 % | 0.56 % | 22.63 % |
|
Price to Book
|
7.03 | 2.88 | 2.41 |
|
P/E
|
18.09 | 42.87 | 25.05 |
|
5yr Avg Cash Conversion Cycle
|
-53.67 Days | 52.03 Days | 109.31 Days |
|
Inventory Days
|
61.98 Days | 112.47 Days | 77.49 Days |
|
Days Receivable
|
35.4 Days | 86.58 Days | 61.31 Days |
|
Days Payable
|
143.49 Days | 159.29 Days | 49.86 Days |
|
5yr Average Interest Coverage Ratio
|
30.59 | 3.01 | 54.21 |
|
5yr Avg ROCE
|
28.37 % | 3.08 % | 14.52 % |
|
5yr Avg Operating Profit Margin
|
20.94 % | 11.84 % | 35.47 % |
|
5 yr average Debt to Equity
|
0.0 | 0.37 | 0.02 |
|
5yr CAGR Net Profit
|
35.58 % | n/a | -2.12 % |
|
5yr Average Return on Assets
|
17.85 % | 1.2 % | 9.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.95 % | 69.84 % | 43.07 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.54 % | -20.12 % | -6.8 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.38 % | 16.13 % | -2.12 % |
|
RPG Life Sciences
|
Orchid Pharma
|
Advanced Enzyme
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|